nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-ED463F21·Framework v5.9·Pipeline v0.4·Evaluated 08 Oct 2026·OECD: 3.2 Public health and health services·Subfield: Experimental and Cognitive Psychology·Basis: Full text·Type: Cross-sectional study

Sleep and circadian health in the UK Biobank: report on the 2023 sleep questionnaire enhancement.

Tse et al.Tse, Yuan, Zisou et al.·2026·Sleep·10.1093/sleep/zsag068 ↗

Primary claim

Approximately one-quarter (25.2%) met the criteria for at least one operationally defined sleep disorder, with insomnia being the most common (14.4%) followed by obstructive sleep apnea (8.0%), restless legs syndrome (4.1%), and frequent nightmares (3.7%).

Supported · large descriptive sample, but self-reported operational definitions lack clinical confirmation
In brief

A useful large-scale sleep phenotyping resource for UK Biobank that enables downstream research, constrained by unvalidated self-reported disorder definitions.

ReliabilityCaveats4 of 4 checks completeRead the 2 entries ↓
Likely to hold — the claim's weakest requirement is that the effect exists at all. Based on how the study was designed and conducted, not on statistics extracted from the paper. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.
Abstract

STUDY OBJECTIVES: Our study introduced the 2023 UK Biobank sleep questionnaire and described variation in sleep health dimensions and the prevalence of disordered sleep.

METHODS: A questionnaire comprising validated measures and bespoke items was developed to capture key self-reported domains of sleep health and symptoms of sleep disorders. We quantified cohort prevalence of operationally defined sleep disorders and assessed the patterning of sleep health dimensions across key sociodemographic and clinically relevant variables.

RESULTS: A total of 183 704 individuals completed at least one module of the questionnaire after email invitation (representing 56 per cent of those with an active email address), and an additional 1352 individuals completed via the participant website. In total 185 056 individuals were included in the analysis. Respondents were predominantly from a White ethnic background (96.8%), had a mean age of 69.9 (SD, 7.5) years, 57.9 per cent were female, and 25.5 per cent were in employment. Compared to non-respondents, respondents were more likely to be female, tended to be better educated, healthier, and exhibit lower levels of socioeconomic deprivation, although baseline sleep variables were similar between respondents and non-respondents. Around 40 per cent of respondents reported sleep duration less than 7 h, and 49 per cent reported poor sleep quality (Pittsburgh Sleep Quality Index >5). Approximately one-quarter (25.2%) met the criteria for at least one operationally defined sleep disorder, with insomnia being the most common (14.4%) followed by obstructive sleep apnea (8.0%), restless legs syndrome (4.1%), and frequent nightmares (3.7%). Sleep disorders were associated with higher levels of anxiety, depression, fatigue, and cognitive complaints.

CONCLUSIONS: Poor sleep quality and operationally defined sleep disorders are common in the UK Biobank cohort. Sleep questionnaire data can now be integrated with a range of biomedical information to advance understanding of sleep.

Key Claims

Primary finding · Supported

Approximately one-quarter (25.2%) met the criteria for at least one operationally defined sleep disorder, with insomnia being the most common (14.4%) followed by obstructive sleep apnea (8.0%), restless legs syndrome (4.1%), and frequent nightmares (3.7%).

Likely to hold — the claim's weakest requirement is that the effect exists at all. Based on how the study was designed and conducted, not on statistics extracted from the paper. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.

large descriptive sample, but self-reported operational definitions lack clinical confirmation

Abstract, Results; Results, Operationally Defined Sleep Disorders; Table 2
Quote verified
Secondary · Supported

Sleep disorders were associated with higher levels of anxiety, depression, fatigue, and cognitive complaints.

descriptive group differences without covariate adjustment or independent symptom validation

Abstract, Results; Results, Operationally Defined Sleep Disorders; Supplementary eTable S6
Quote verified
Secondary · Supported

Around 40 per cent of respondents reported sleep duration less than 7 h, and 49 per cent reported poor sleep quality (Pittsburgh Sleep Quality Index >5).

direct respondent-level frequencies from a selected older cohort

Abstract, Results; Results, Sleep Health Dimensions; Supplementary eTable S2
Quote verified

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#contribution

Fills a documented measurement gap

The 138-item questionnaire expands UK Biobank beyond the single-item sleep measures criticised in the Introduction and supports multi-domain sleep and circadian phenotyping.

↳ Introduction, paragraphs 2–4; Methods, Development of the Sleep Questionnaire

#methodological rigour

Transparent descriptive phenotype construction

Case definitions draw on diagnostic criteria, scale scoring, and working-group review, while two analysts independently applied and cross-checked the operational phenotypes.

↳ Methods, Defining Outcomes/Phenotypes and Analysis

#positioning

Selection limits are directly examined

Respondents are compared with invited non-respondents and the broader cohort, and the Discussion explicitly rejects interpreting the reported frequencies as general-population prevalence.

↳ Results, Respondent Characteristics, Table 1; Discussion, paragraph 2

Limitations

#methodological rigour

Case definitions lack clinical validation

Operational classifications were not confirmed by clinical interviews, polysomnography, or prospective sleep–wake monitoring, and some definitions use single items or criteria with uncertain predictive validity.

↳ Discussion, paragraph 3

#application pathway

Transferability is substantially constrained

Respondents were predominantly White, older, healthier, and less deprived, limiting application of the observed distributions to other populations and settings.

↳ Abstract, Results; Results, Respondent Characteristics; Discussion, paragraph 2

#reporting

Minor reporting and availability inconsistencies

Employment percentages differ across the Abstract and Results, and the public GitHub address contains a literal “[Journal]” placeholder, reducing confidence in those reporting details.

↳ Abstract, Results; Results, Sleep Health Dimensions; Methods, Analysis

Does this match your read? Add your assessment ↓

Nabu Commentary

The paper’s strongest contribution is the addition of detailed sleep and circadian phenotyping to a cohort with extensive linked biomedical data. Its descriptive execution is transparent, including explicit missing-data rules, independent coding, phenotype cross-checks, and respondent versus non-respondent comparisons. The score remains below the upper quality range because proposed disorder definitions are not clinically validated and some rely on limited or adapted questionnaire features. Impact is strongest for cumulative UK Biobank research, while broader translation is restricted by measurement validity and cohort selection.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
3.8±0.1

Contribution
3.8

The paper adds a 138-item, 11-module sleep questionnaire and operational phenotype framework to a heavily used cohort, addressing the limitations of earlier single-item measures. Its advance is principally infrastructural because the disorder definitions are not clinically validated.

Introduction, paragraphs 2–4; Methods, Development of the Sleep Questionnaire and Defining Outcomes/Phenotypes

Enhanced capture of probable sleep disorders at scale through comprehensive questionnaire measures would represent a key advance relative to previous work.

Methodological Rigour
3.7

The descriptive design includes explicit missing-data rules, respondent versus non-respondent comparisons, independent coding by two analysts, and respondent-level phenotype checks. Diagnostic validity remains uncertain because classifications rely on self-report and some definitions use single items or adapted criteria.

Methods, Defining Outcomes/Phenotypes and Analysis; Discussion, paragraphs 2–4

our case definitions should be considered suggestive of disorder rather than definitive

Reporting
3.9

The paper follows a coherent sequence from questionnaire development through phenotype coding and descriptive results, while consistently identifying cases as operational or possible. Association wording is somewhat loose because no inferential analyses or covariate adjustment were performed, but the Discussion makes that boundary explicit.

Abstract; Methods, Analysis; Discussion, paragraph 3

no statistical analyses or covariate adjustments were performed

Positioning
3.8

The paper relates the resource to low-resolution sleep measurement in UK Biobank and interprets findings in light of healthy-volunteer selection and self-report misclassification. External benchmarking is informal, and comparison with other cohort-level sleep phenotyping initiatives is limited.

Introduction, paragraphs 2–4; Discussion, paragraphs 1–3

findings cannot be generalized to different populations and settings, nor be interpreted as general population prevalence estimates

Reliability

Caveats4 of 4 checks


Results checkNoted

One reported value does not reconcile, but the key claims do not rest on it.

Reporting and transparencyNoted

Reference [19] is assigned to both the UK Biobank cohort description and the Berlin Questionnaire; the correct citation cannot be established from the supplied text.

Conflict of interest: not stated · Ethics approval: declared · Preregistration: not stated · Data availability: declared · Code availability: declared

Reference IntegrityClean

43 references in manuscript 42 of 42 checkable references found in an index 1 have no canonical index record — counted, but not index-checkable 1 reference confirmed by manual review

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 17 Oct 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Mental health · Other mental disorders
Type of advanceEmpirical
Route to useNot stated
AdvanceExtends
BeneficiariesCatch-all cause
CitationsToo early
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessFoundational
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The primary claim is a descriptive prevalence observation from a one-time questionnaire with no controlled, piloted or validated demonstration of anything working beyond the measurement itself.

The paper's stated uses of its findings are research uses only, such as integrating the data for GWAS, Mendelian randomization and other analyses to advance understanding of sleep.

Pathway

Researchers using the released phenotype definitions and questionnaire data in UK Biobank would run genetic, biomarker and Mendelian randomization analyses to reveal sleep disorder etiology and health consequences.

Barrier

Case definitions rest on self-report without clinical interviews or polysomnography, so phenotypes are only suggestive and require validation before downstream findings are trusted.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Untangling the mechanisms of sleep restriction therapy

    Stanyer, Skeldon, Kyle · 2025 · Clinical medicine

    Primary claim

    it seems likely that adhering to SRT recommendations—that is, reducing sleep opportunity and following prescribed bed and rise-times—drives rapid improvement in nocturnal symptom severity.

    Tentative
    Evidence Score
    3.3±0.2
    Reliability
    No concerns
  2. Enhancing sleep slow waves with auditory stimulation in people with Parkinson's disease: a randomized proof-of-concept trial

    Schreiner, Horlacher, Fattinger, et al. · 2026 · Clinical medicine

    Primary claim

    PTAS increased low-frequency SWA by almost 30% during ON windows, with corresponding increases in slow-wave amplitudes, in 21 analyzed participants.

    Tentative
    Evidence Score
    3.6±0.2
    Reliability
    Caveats
  3. Mind the gap: obtaining reliable sleep estimates and the diagnostic value of sleep discrepancy in individuals with Alzheimer's disease and Lewy body disease

    Gabb, Blackman, Morrison, et al. · 2026 · Clinical medicine

    Primary claim

    Subjective sleep and subjective-objective sleep discrepancy discriminated between cohorts with 80% accuracy.

    Tentative
    Evidence Score
    3.3±0.2
    Reliability
    Caveats

How the rubric works →